ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CBF Cobra Bio-Man.

2.25
0.00 (0.00%)
16 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cobra Bio-Man. LSE:CBF London Ordinary Share GB0031704835 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.25 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Directorate Change

02/12/2003 7:01am

UK Regulatory


RNS Number:7232S
Cobra Bio-Manufacturing PLC
02 December 2003


For Immediate Release                             2 December 2003




                           COBRA BIOMANUFACTURING PLC



                               Board Appointment



Cobra Biomanufacturing Plc, the international manufacturer of
biopharmaceuticals, today announces the appointment of Michael Gatenby to the
Board as a non-executive director.



Michael graduated with Honours in Law from Cambridge. He is a chartered
accountant and was a director of Hill Samuel and Co and Vice Chairman of
Charterhouse Bank. He is currently a director of Johnson Service Group Plc,
Porvair Plc, SRS Technology Group Plc and Protherics Plc and he is also a
Trustee/Director of the Stroke Association.



Michael Gatenby has been a Director of the following companies within the last
five years:



Former directorships (and year of resignation):



1980    Bridport plc (resigned 1999 following takeover)

1996    SGB Group plc (resigned 2000 following takeover)

1997    Powell Duffryn plc - Vice-Chairman (resigned following takeover 2000)

1999    Tarmac plc (resigned 2000 following takeover)



There are no further matters to be disclosed in accordance with paragraph 'f' of
schedule 2 of the AIM rules.



Commenting on the appointment, Peter Fothergill, Chairman commented: "I am
delighted that Michael has agreed to join the Board at this exciting time as his
background and experience can make a real contribution to the challenges ahead."



                                    - ENDS -





For further information, please contact:


Cobra Biomanufacturing Plc                         Tel: +44 (0) 1782 714 181
David Thatcher, Chief Executive Officer

Buchanan Communications                            Tel: +44 (0) 207 466 5000
Mark Court/Rebecca Skye Dietrich






                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

BOAKGMGZRMRGFZM

1 Year Cobra Bio-manufacturing Chart

1 Year Cobra Bio-manufacturing Chart

1 Month Cobra Bio-manufacturing Chart

1 Month Cobra Bio-manufacturing Chart

Your Recent History

Delayed Upgrade Clock